Reduced vasorelaxant effect of carbon monoxide in diabetes and the underlying mechanisms

Diabetes

Volumn 50, Issue 1, 2001, Pages 166-174

  Wang, Rui ^a   Wang, Zunzhe ^b   Wu, Lingyun ^a   Hanna, Salma Toma ^a   Peterson Wakeman, Robert ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; POTASSIUM CHANNEL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 0035149638     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.1.166     Document Type: Article

References (43)

1. Resurgence of carbon monoxide: An endogenous gaseous vasorelaxing factor
2. Ca channels in vascular smooth muscle cells
3. Ca channels by carbon monoxide in vascular smooth muscle cells
4. Carbon monoxide-induced vasorelaxation and the underlying mechanisms
5. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide
6. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP
7. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation
8. Does carbon monoxide have a physiological function?
9. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats
10. Carbon monoxide in chronic uraemia related to erythroprotein treatment and smoking habits
11. + channels?
12. Diabetes and hypertensive vascular disease: Mechanisms and treatment
13. Diabetes mellitus and hypertension
14. The pancreas: Specific organ involvement
15. 2+ flux and blood pressure regulation in streptozotocin-induced diabetic rats
16. 2+ efflux and hypertension in Zucker obese rats
17. Kinin B2 receptor-mediated contraction of tail artery from normal or streptozotocin-induced diabetic rats
18. Altered L-type voltage-dependent calcium channels in diabetic vascular smooth muscle cells
19. Diabetes-related abnormal calcium mobilization in smooth muscle cells are induced by hyperosmolality
20. Occurrence and putative hormone regulatory function of a constitutive heme oxygenase in rat pancreatic islets
21. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats
22. Oxygen-derived free radicals and melatonin in vascular smooth muscles from spontaneously hypertensive rats
23. Two types of calcium channels in isolated smooth muscle cells from rat tail artery
24. + channel genes in mesenteric artery smooth muscle cells
25. Effect of glucose on endothelin-1-induced calcium transients in cultured bovine retinal pericytes
26. Roles of heme oxygenase/carbon monoxide system in genetically hypertensive rats
27. Induction of heme oxygenase produces load-independent cardioprotective effects in hypertensive rats
28. Heme oxygenase-l-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo
29. Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: An immunocytochemical and confocal microscopical study
30. Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: A new test for monitoring the disease?
31. Deglycation of glycated proteins with hydrazine analogues
32. Lipoprotein glycation and its metabolic consequence
33. Kinetic features of ascorbic acid oxidase after partial deglycation
34. Effect of chemical glycosylation of Rnase A on the protein stability and surface histidines accessibility in immobilized metal ion affinity electrophoresis (IMAGE) system
35. Glucose modification of human serum albumin: A structural study
36. Glycation of lens MIP26 affects the permeability in reconstituted liposomes
37. Foot problems in diabetes
38. A non-uniform three-dimensional perfusion model of rat tail heat transfer
39. Impaired thermoregulatory cutaneous vasodilation in spontaneously hypertensive rats
40. Inhibitory effect of OP-41483.α-CD, a prostacyclin analog, on peripheral vascular lesion models in rats
41. Vascular assessment in the neuropathic diabetic foot
42. Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting?
43. Venous distension in the diabetic neuropathic foot (physical sign of arteriovenous shunting)